Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.
News|Articles|March 1, 2006
First-time generic approvals
Isradipine capsules 2.5 and 5 mg (equiv to Dynacirc capsules)
Advertisement
Isradipine capsules 2.5 and 5 mg (equiv to Dynacirc capsules)
ABRIKA PHARMACEUTICALS
Hydrocodone and acetaminophen tablets 5 mg/300 mg (equiv to Norco tablets)
MIKART
Clopidogrel tablets 75 mg (equiv to Plavix tablets)
APOTEX
Testosterone gel, 1% (equiv to Androgel)
WATSON
Advertisement
Related to this article
Women face more gaps in healthcare than men, from missed screenings, undertreatment and biased coverage. PBMs are launching programs to address some of the gaps.
Navitus launched three modular options that let plan sponsors manage diabetes, weight, and lifestyle therapy access, cost, and outcomes with guaranteed ROI.
StarkRx has launched as a modular, cost-plus pharmacy benefit management company for self-funded employers using Judi Health’s PBM, Judi Rx, to administer claims.
National Alliance names Jenny Goins interim CEO after former leader’s arrest; details emerge on charges, firing timeline, and impact on healthcare policy circles.
Only 19% use AI predictive models in cancer care despite strong belief in impact; 2026 Oncology Care Index highlights reimbursement, training, funding barriers.
Hispanic HIV incidence rose 16.8% in antisanctuary counties after the 2018 public charge announcement, relative to baseline counties, a new study found.
A review of randomized clinical trials, nonrandomized trials and case reports suggests that the inflammatory bowel disease risk from treatment with IL-17 inhibitors is low.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
National Alliance names interim head after arrest of its president
2
The IBD risk among patients with hidrandentitis suppurtiva treated with IL-17 inhibitors: Low but not nothing
3
Why people under 50 may develop fatty liver disease
4
The quest to keep skin from aging may lead here
5